Eli Lilly & Co. (LLY)
993.20
+10.98
(+1.12%)
USD |
NYSE |
Dec 10, 16:00
994.88
+1.68
(+0.17%)
After-Hours: 18:06
Eli Lilly Market Cap: 888.93B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.78B |
| Regeneron Pharmaceuticals, Inc. | 76.34B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 4.242B |
| Moderna, Inc. | 11.34B |
Market Cap Related Metrics
| PE Ratio | 49.12 |
| PS Ratio | 15.24 |
| PEG Ratio | 0.4054 |
| Price to Book Value | 37.36 |
| Price to Free Cash Flow | 140.68 |
| Price | 993.20 |
| Earnings Yield | 2.04% |
| PEGY Ratio | 0.4033 |
| Operating PE Ratio | 34.31 |
| Normalized PE Ratio | 43.99 |